New drug trial targets debilitating fungal sinus disease

NCT ID NCT04684524

Summary

This study tested whether the drug dupilumab could help control allergic fungal rhinosinusitis (AFRS), a severe sinus condition. It involved 62 adults and adolescents with confirmed AFRS who received either dupilumab or a placebo for a year. The main goal was to see if the drug could reduce sinus blockage seen on CT scans and improve symptoms like congestion and loss of smell.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC FUNGAL RHINOSINUSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Advanced ENT and Allergy Site Number : 8400004

    Louisville, Kentucky, 40220, United States

  • Alamo ENT Associates Site Number : 8400018

    San Antonio, Texas, 78258, United States

  • Asthma Allergy & Immunology Clinical Research Unit Site Number : 8400001

    Tampa, Florida, 33613, United States

  • Eastern Virginia Medical School (EVMS) Medical Group - Otola Site Number : 8400008

    Norfolk, Virginia, 23507, United States

  • Emory University Hospital Midtown Campus Site Number : 8400009

    Atlanta, Georgia, 30308, United States

  • Investigational Site Number : 0320001

    CABA, Buenos Aires, C1425BEN, Argentina

  • Investigational Site Number : 0320002

    Buenos Aires, C1121ABE, Argentina

  • Investigational Site Number : 0320003

    CABA, Buenos Aires, C1414AIF, Argentina

  • Investigational Site Number : 0320004

    Mendoza, 5500, Argentina

  • Investigational Site Number : 0320005

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number : 1240001

    Vancouver, British Columbia, V6Z 1Y6, Canada

  • Investigational Site Number : 1560001

    Beijing, 100730, China

  • Investigational Site Number : 1560002

    Nanjing, 210029, China

  • Investigational Site Number : 1560003

    Chengdu, 610041, China

  • Investigational Site Number : 1560004

    Changsha, 410013, China

  • Investigational Site Number : 1560005

    Beijing, 100050, China

  • Investigational Site Number : 1560006

    Hangzhou, 310003, China

  • Investigational Site Number : 1560008

    Taiyuan, 030001, China

  • Investigational Site Number : 1560009

    Shanghai, 200030, China

  • Investigational Site Number : 1560011

    Qingdao, 266555, China

  • Investigational Site Number : 1560012

    Hefei, China

  • Investigational Site Number : 1560013

    Fuzhou, 350005, China

  • Investigational Site Number : 3560003

    Coimbatore, 641028, India

  • Investigational Site Number : 3560006

    Jodhpur, 342005, India

  • Investigational Site Number : 3560008

    New Delhi, 110 062., India

  • Investigational Site Number : 3760001

    Petah Tikva, 49100, Israel

  • Investigational Site Number : 3760002

    Rehovot, 76100, Israel

  • Investigational Site Number : 3920001

    Meguro-ku, Tokyo, 153-8515, Japan

  • Investigational Site Number : 3920003

    Shinagawa-ku, Tokyo, 141-0001, Japan

  • Investigational Site Number : 3920006

    Shizuoka, Shizuoka, 420-0853, Japan

  • Investigational Site Number : 3920008

    Bunkyo-ku, Tokyo, 113-8431, Japan

  • Investigational Site Number : 3920009

    Shinjuku-ku, Tokyo, 160-8582, Japan

  • Investigational Site Number : 3920010

    Isehara, Kanagawa, 2591193, Japan

  • Investigational Site Number : 6820001

    Riyadh, 22252, Saudi Arabia

  • Investigational Site Number : 6820002

    Riyadh, 12713, Saudi Arabia

  • Investigational Site Number : 7920001

    Istanbul, 34093, Turkey (Türkiye)

  • Investigational Site Number : 7920003

    Izmir, 35340, Turkey (Türkiye)

  • Investigational Site Number : 7920004

    Adana, 01380, Turkey (Türkiye)

  • Investigational Site Number : 7920005

    Malatya, 44280, Turkey (Türkiye)

  • Investigational Site Number : 7920006

    Izmir, 35100, Turkey (Türkiye)

  • Investigational Site Number : 7920007

    Istanbul, 34865, Turkey (Türkiye)

  • National Allergy and Asthma Research, LLC Site Number : 8400002

    Charleston, South Carolina, 29407, United States

  • REX Clinical Trials Site Number : 8400017

    Beaumont, Texas, 77701-3713, United States

  • South Louisiana Ear, Nose, Throat and Facial Plastic Surgery Site Number : 8400019

    Mandeville, Louisiana, 70471, United States

  • USA Clinical Trials Site Number : 8400020

    San Antonio, Texas, 78229, United States

  • Ut- Houston Medical School Site Number : 8400010

    Houston, Texas, 77030, United States

  • Vanderbilt University Medical Center Site Number : 8400013

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.